Novartis India Ltd
Novartis India Ltd (NOVARTIND) last traded at ₹1,475, a market capitalisation of ₹3,643 crore, on a P/E of 37.3. Over the past 52 weeks the stock has ranged between ₹750 and ₹1,780. Novartis India Ltd last reported results for the quarter ended Jun 2026, with sales of ₹104 crore and net profit of ₹32 crore. The next scheduled event is an other on 30 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Novartis India Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Novartis India Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹104 cr, up 18.2% from ₹88 cr a year earlier. Net profit was ₹32 cr, up 14.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 87 | 93 | 84 | 88 | 90 | 86 | 91 | 104 |
| Expenses | 69 | 67 | 60 | 60 | 66 | 64 | 70 | 69 |
| Operating profit | 18 | 26 | 24 | 27 | 24 | 22 | 21 | 35 |
| OPM % | 21% | 28% | 29% | 31% | 26% | 26% | 23% | 34% |
| Other income | 10 | 11 | 11 | 11 | 9 | 9 | 10 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Profit before tax | 28 | 35 | 34 | 37 | 33 | 30 | 30 | 43 |
| Tax % | 26% | 28% | 14% | 26% | 26% | 46% | 16% | 25% |
| Net profit | 20 | 25 | 29 | 28 | 24 | 16 | 25 | 32 |
| EPS (₹) | 8.27 | 10.31 | 11.87 | 11.19 | 9.81 | 6.52 | 10.23 | 13.05 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Novartis India Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 381 | 400 | 379 | 335 | 356 | 354 | 371 |
| Operating profit | 27 | 27 | 65 | 65 | 91 | 94 | 102 |
| OPM % | 7% | 7% | 17% | 19% | 26% | 27% | 27% |
| Net profit | 21 | -4 | 103 | 85 | 101 | 93 | 98 |
| EPS (₹) | 8.46 | -1.51 | 41.86 | 34.50 | 40.87 | 37.74 | 39.61 |
TTM is the trailing twelve months to the most recent quarter.
Novartis India Ltd growth and returns
- 10 Years
- -6%
- 5 Years
- -1%
- 3 Years
- -2%
- TTM
- 5%
- 10 Years
- -7%
- 5 Years
- 35%
- 3 Years
- -3%
- TTM
- -5%
- 10 Years
- 8%
- 5 Years
- 14%
- 3 Years
- 28%
- 1 Year
- 60%
- 10 Years
- 8%
- 5 Years
- 11%
- 3 Years
- 12%
- Last Year
- 12%
Novartis India Ltd shareholding pattern
Promoters held 70.68% at Jul 2026, broadly unchanged since Sep 2025. FIIs 0.15% and DIIs 1.39%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 70.68% | 70.68% | 70.68% | 70.68% | 70.68% | 70.68% | 70.68% | 70.68% |
| FIIs | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | 0.17% | 0.16% | 0.15% |
| DIIs | 0.53% | 0.53% | 0.53% | 0.53% | 0.63% | 0.53% | 1.35% | 1.39% |
| Public | 28.60% | 28.61% | 28.60% | 28.61% | 28.50% | 28.60% | 27.81% | 27.79% |
| No. of shareholders | 38,926 | 39,133 | 39,040 | 39,353 | 39,468 | 38,116 | 36,502 | 36,706 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Novartis India Ltd events
The next scheduled event is an other on 30 Sept 2026.
- OtherTermination of distribution and promotion agreement with Dr. Reddy's Laboratories
See the full results calendar for every Indian company reporting in the next 30 days.
Novartis India Ltd corporate filings
- Outcome of the meeting of the Board of Directors of the Company held on August 17, 2026Otherslow impact
Cruxal's analysis: Novartis India Limited has announced a board-approved proposal to change the company's…
Read the full analysis - Intimation of the outcome of the Board Meeting held today i.e. August 07, 2026Othersmedium impact
Cruxal's analysis: Novartis India Limited has announced the termination of its February 2022 distribution…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Novartis India Ltd
Cruxal reads every Novartis India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.